Zomedica Pharmaceuticals Corp (ZOM) — Tangible Net Worth Ratio
Zomedica Pharmaceuticals Corp (ZOM) has a Tangible Net Worth Ratio of 67.7% as of March 2025. This metric is calculated by deducting intangible assets ($42.77 Million) from net assets ($132.44 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Zomedica Pharmaceuticals Corp book value and equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zomedica Pharmaceuticals Corp Tangible Net Worth Ratio (2012–2024)
This chart shows how Zomedica Pharmaceuticals Corp's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of March 2025, the ratio stands at 67.7%, reflecting net assets of $132.44 Million with intangible assets of $42.77 Million USD. Also explore net asset momentum of Zomedica Pharmaceuticals Corp to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zomedica Pharmaceuticals Corp (2012–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Zomedica Pharmaceuticals Corp from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Zomedica Pharmaceuticals Corp.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.1% | $195.66 Million | $52.54 Million | $207.36 Million | ▼ -3.8 pp |
| 2023 | 76.9% | $240.02 Million | $55.36 Million | $253.20 Million | ▼ -7.4 pp |
| 2022 | 84.4% | $267.39 Million | $41.80 Million | $279.61 Million | ▼ -3.3 pp |
| 2021 | 87.6% | $270.89 Million | $33.52 Million | $280.40 Million | ▼ -11.6 pp |
| 2020 | 99.3% | $51.07 Million | $376.59K | $66.14 Million | ▲ +25.2 pp |
| 2019 | 74.1% | $2.10 Million | $543.39K | $4.18 Million | ▼ -25.6 pp |
| 2018 | 99.6% | $3.66 Million | $13.06K | $6.03 Million | ▼ 0.0 pp |
| 2017 | 99.7% | $4.39 Million | $15.14K | $5.22 Million | ▲ +7.3 pp |
| 2016 | 92.3% | $4.13 Million | $317.94K | $4.88 Million | ▲ +0.7 pp |
| 2015 | 91.6% | $3.71 Million | $311.02K | $3.86 Million | ▼ -8.4 pp |
| 2014 | 100.0% | $141.41K | $0.00 | $145.34K | ▲ +0.0 pp |
| 2013 | 100.0% | $206.38K | $0.00 | $211.54K | ▲ +0.0 pp |
| 2012 | 100.0% | $96.34K | $0.00 | $97.31K | — |